Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Johnson & Johnson    JNJ

JOHNSON & JOHNSON

(JNJ)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations

Update : N.Y. Jury Delivers $25 Million Judgment Against Johnson & Johnson -- Bloomberg

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/21/2019 | 01:42pm EDT

(Adds company comment)

-- A New York jury said Johnson & Johnson (JNJ) must pay $25 million to a woman who claims she got cancer by using the company's products, Bloomberg reports Tuesday.

-- The woman alleged she got a rare type of cancer, linked to asbestos, from some of the company's products which contain talc, the report said.

-- The $25 million is for compensatory damages, and the jury will reconvene next week to consider a punitive penalty, the report said.

-- Johnson & Johnson has denied all allegations that its baby powder contained asbestos.

-- Johnson & Johnson said "This trial suffered significant legal and evidentiary errors," adding it had moved for a mistrial. The company also said "we believe these errors will warrant a reversal on appeal."

Full story: https://www.bloomberg.com/news/articles/2019-05-21/johnson-johnson-loses-25-million-new-york-talc-verdict?utm_source=google&utm_medium=bd&cmpId=google

Write to Stephen Nakrosis at stephen.nakrosis@wsj.com

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on JOHNSON & JOHNSON
10/19JOHNSON & JOHNSON : J&J Recalls Baby Powder on Asbestos Concern -- 3rd Update
DJ
10/19J&J Recalls Baby Powder For Asbestos -- WSJ
DJ
10/18MARKET SNAPSHOT: Dow Ends Lower Pressured By Boeing, Johnson & Johnson, Despi..
DJ
10/18JOHNSON & JOHNSON : J&J Recalls Baby Powder on Asbestos Concern -- 2nd Update
DJ
10/18JPMORGAN CHASE, FACEBOOK, COCA-COLA : Stocks That Defined the Week
DJ
10/18CARDINAL HEALTH : Opioid negotiations fail to produce deal just before trial
AQ
10/18Johnson & Johnson Down Over 5%, on Pace for Largest Percent Decrease Since De..
DJ
10/18J&J Recalls Baby Powder on Asbestos Concern -- Update
DJ
10/18JOHNSON & JOHNSON : J&J recalls baby powder after trace asbestos found in bottle
AQ
10/18JOHNSON & JOHNSON : J&J Recalls One Baby Powder Lot After Test Shows Subordinate..
DJ
More news
Financials (USD)
Sales 2019 82 226 M
EBIT 2019 25 622 M
Net income 2019 19 665 M
Debt 2019 7 881 M
Yield 2019 2,94%
P/E ratio 2019 17,7x
P/E ratio 2020 16,6x
EV / Sales2019 4,19x
EV / Sales2020 3,93x
Capitalization 337 B
Chart JOHNSON & JOHNSON
Duration : Period :
Johnson & Johnson Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends JOHNSON & JOHNSON
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 19
Average target price 149,16  $
Last Close Price 127,70  $
Spread / Highest target 35,5%
Spread / Average Target 16,8%
Spread / Lowest Target 1,02%
EPS Revisions
Managers
NameTitle
Alex Gorsky Chairman & Chief Executive Officer
Joseph J. Wolk Chief Financial Officer & Executive Vice President
Paulus Stoffels Chief Scientific Officer
Charles O. Prince Independent Director
William David Perez Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
JOHNSON & JOHNSON5.52%337 021
ROCHE HOLDING AG18.49%250 869
MERCK AND COMPANY10.82%216 813
PFIZER-16.47%201 662
NOVARTIS15.95%198 751
NOVO NORDISK AS19.37%123 560